{
  "report_rows": [
    {
      "kpi": "Adjusted FFO/share",
      "prediction": "BEAT",
      "answer": "pred ~$0.400 vs. cons $0.395 (VA, Aug. 4; definition UNVERIFIED)",
      "confidence": "LOW"
    },
    {
      "kpi": "Life-science same-store NOI growth",
      "prediction": "MISS",
      "answer": "pred ~-6.5% vs. cons -5.72% (VA, Aug. 4)",
      "confidence": "LOW"
    },
    {
      "kpi": "Senior-living same-store NOI growth",
      "prediction": "MISS",
      "answer": "pred ~+16.0% vs. cons +16.97% (VA, Aug. 4)",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 FFO as Adjusted ($/share)",
      "prediction": "BETTER",
      "answer": "guide ~$1.71-$1.75 vs. cons $1.570 (VA, Aug. 4; guide from May 5 release)",
      "confidence": "LOW"
    },
    {
      "kpi": "Life-science occupancy commentary (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "reiterate improving through year-end vs. no reliable numeric consensus",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -5.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 maintained guide plus lab miss pressures forward estimates",
  "day5_confidence": "LOW"
}